RU2493149C2 - Замещенные метилфенилкетоны, пригодные для использования в качестве ингибиторов pde4 - Google Patents

Замещенные метилфенилкетоны, пригодные для использования в качестве ингибиторов pde4 Download PDF

Info

Publication number
RU2493149C2
RU2493149C2 RU2009128191/04A RU2009128191A RU2493149C2 RU 2493149 C2 RU2493149 C2 RU 2493149C2 RU 2009128191/04 A RU2009128191/04 A RU 2009128191/04A RU 2009128191 A RU2009128191 A RU 2009128191A RU 2493149 C2 RU2493149 C2 RU 2493149C2
Authority
RU
Russia
Prior art keywords
compound
dichloropyridin
ethanone
acetyl
acetamide
Prior art date
Application number
RU2009128191/04A
Other languages
English (en)
Russian (ru)
Other versions
RU2009128191A (ru
Inventor
Якоб Фелдинг
Симон Фельдбек НИЛЬСЕН
Original Assignee
Лео Фарма А/С
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Лео Фарма А/С filed Critical Лео Фарма А/С
Publication of RU2009128191A publication Critical patent/RU2009128191A/ru
Application granted granted Critical
Publication of RU2493149C2 publication Critical patent/RU2493149C2/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/61—Halogen atoms or nitro radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/08—Antiseborrheics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Communicable Diseases (AREA)
  • Toxicology (AREA)
  • Oncology (AREA)
  • Pain & Pain Management (AREA)
  • Pyridine Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
RU2009128191/04A 2006-12-22 2007-12-21 Замещенные метилфенилкетоны, пригодные для использования в качестве ингибиторов pde4 RU2493149C2 (ru)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US87168906P 2006-12-22 2006-12-22
US60/871,689 2006-12-22
US94547007P 2007-06-21 2007-06-21
US60/945,470 2007-06-21
PCT/DK2007/000564 WO2008077404A1 (en) 2006-12-22 2007-12-21 Substituted acetophenones useful as pde4 inhibitors

Publications (2)

Publication Number Publication Date
RU2009128191A RU2009128191A (ru) 2011-01-27
RU2493149C2 true RU2493149C2 (ru) 2013-09-20

Family

ID=39156588

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2009128191/04A RU2493149C2 (ru) 2006-12-22 2007-12-21 Замещенные метилфенилкетоны, пригодные для использования в качестве ингибиторов pde4

Country Status (23)

Country Link
US (3) US8148537B2 (https=)
EP (1) EP2125736B1 (https=)
JP (1) JP5342451B2 (https=)
KR (1) KR101507717B1 (https=)
AT (1) ATE503742T1 (https=)
AU (1) AU2007336538B2 (https=)
BR (1) BRPI0721113A2 (https=)
CA (1) CA2673370C (https=)
CR (1) CR10877A (https=)
CY (1) CY1111596T1 (https=)
DE (1) DE602007013617D1 (https=)
DK (1) DK2125736T3 (https=)
GT (1) GT200900172A (https=)
HR (1) HRP20110464T1 (https=)
IL (1) IL199383A (https=)
MX (1) MX2009006593A (https=)
MY (1) MY146022A (https=)
NO (1) NO20092372L (https=)
NZ (1) NZ577863A (https=)
PL (1) PL2125736T3 (https=)
PT (1) PT2125736E (https=)
RU (1) RU2493149C2 (https=)
WO (1) WO2008077404A1 (https=)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2814175C2 (ru) * 2017-06-20 2024-02-26 Юнион Терапьютикс А/С Способы получения 1,3-бензодиоксольных гетероциклических соединений

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ601001A (en) 2009-12-22 2014-07-25 Leo Pharma As Pharmaceutical composition comprising solvent mixture and a vitamin d derivative or analogue
BR112012015433B8 (pt) 2009-12-22 2020-03-03 Leo Pharma As composição farmacêutica substancialmente anidra para aplicação cutânea
MX2012007234A (es) 2009-12-22 2012-07-30 Leo Pharma As Nanocristales de monohidrato de calciprotiol.
CN102775345A (zh) * 2011-05-13 2012-11-14 上海特化医药科技有限公司 制备罗氟司特的方法及中间体
EP2925364A1 (en) * 2012-11-30 2015-10-07 Leo Pharma A/S A method of inhibiting the expression of il-22 in activated t-cells
WO2014096018A1 (en) * 2012-12-19 2014-06-26 Leo Pharma A/S Methods for the preparation of substituted acetophenones
SI3060551T1 (sl) * 2013-10-22 2019-11-29 Chiesi Farm Spa Postopek za pripravo inhibitorja PDE4
MX2016016378A (es) * 2014-06-23 2017-10-16 Leo Pharma As Metodos para la preparacion de compuestos heterociclicos de 1,3-benzodioxol.
WO2017089347A1 (en) 2015-11-25 2017-06-01 Inserm (Institut National De La Sante Et De La Recherche Medicale) Methods and pharmaceutical compositions for the treatment of braf inhibitor resistant melanomas
DK3390407T3 (da) 2015-12-18 2023-11-06 Union Therapeutics As Fremgangsmåder til fremstilling af heterocykliske 1,3-benzodioxolforbindelser
KR101702648B1 (ko) * 2016-05-10 2017-02-03 주식회사 엑티브온 피부 외용제용 보존제, 이를 포함하는 화장료 조성물 및 약학 조성물
DK3642210T3 (da) 2017-06-20 2024-12-09 Union Therapeutics As Fremgangsmåder til fremstilling af heterocykliske 1,3-benzodioxolforbindelser
EP3838967A1 (en) * 2019-12-16 2021-06-23 Spago Nanomedical AB Immobilization of phenolic compounds
CN117924243B (zh) * 2024-01-16 2025-09-12 沈阳药科大学 一种喹啉衍生物及其药用组合物和应用

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995020578A1 (en) * 1994-01-26 1995-08-03 Rhone-Poulenc Rorer Limited SUBSTITUTED AROMATIC COMPOUNDS AS c.AMP PHOSPHODIESTERASE- AND TNF-INHIBITORS
EP0943613A1 (en) * 1996-11-19 1999-09-22 Kyowa Hakko Kogyo Kabushiki Kaisha Oxygenic heterocyclic compounds
RU2188188C2 (ru) * 1992-12-23 2002-08-27 Селлтек Лимитед Трехзамещенные фенильные производные
WO2006135828A2 (en) * 2005-06-10 2006-12-21 Memory Pharmaceuticals Corporation Trisubstituted amines as phosphodiesterase 4 inhibitors

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE325110T1 (de) * 1995-05-19 2006-06-15 Kyowa Hakko Kogyo Kk Sauerstoff enthaltende heterocyclische verbindungen
US6514996B2 (en) * 1995-05-19 2003-02-04 Kyowa Hakko Kogyo Co., Ltd. Derivatives of benzofuran or benzodioxole
MXPA05009921A (es) * 2003-03-17 2005-11-04 Kyowa Hakko Kogyo Kk Agentes terapeuticos y/o preventivos para enfermedades cutaneas cronicas.
WO2006040645A1 (en) * 2004-10-11 2006-04-20 Ranbaxy Laboratories Limited N-(3,5-dichloropyridin-4-yl)-2,4,5-alkoxy and 2,3,4-alkoxy benzamide derivatives as pde-iv (phophodiesterase type-iv) inhibitors for the treatment of inflammatory diseases such as asthma

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2188188C2 (ru) * 1992-12-23 2002-08-27 Селлтек Лимитед Трехзамещенные фенильные производные
WO1995020578A1 (en) * 1994-01-26 1995-08-03 Rhone-Poulenc Rorer Limited SUBSTITUTED AROMATIC COMPOUNDS AS c.AMP PHOSPHODIESTERASE- AND TNF-INHIBITORS
EP0943613A1 (en) * 1996-11-19 1999-09-22 Kyowa Hakko Kogyo Kabushiki Kaisha Oxygenic heterocyclic compounds
WO2006135828A2 (en) * 2005-06-10 2006-12-21 Memory Pharmaceuticals Corporation Trisubstituted amines as phosphodiesterase 4 inhibitors

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2814175C2 (ru) * 2017-06-20 2024-02-26 Юнион Терапьютикс А/С Способы получения 1,3-бензодиоксольных гетероциклических соединений

Also Published As

Publication number Publication date
WO2008077404A1 (en) 2008-07-03
US20130012716A1 (en) 2013-01-10
KR20090098990A (ko) 2009-09-18
EP2125736A1 (en) 2009-12-02
IL199383A (en) 2015-02-26
PL2125736T3 (pl) 2011-09-30
US8324394B2 (en) 2012-12-04
MY146022A (en) 2012-06-15
MX2009006593A (es) 2009-07-02
AU2007336538A1 (en) 2008-07-03
NZ577863A (en) 2012-04-27
PT2125736E (pt) 2011-07-01
DE602007013617D1 (de) 2011-05-12
RU2009128191A (ru) 2011-01-27
US8148537B2 (en) 2012-04-03
AU2007336538B2 (en) 2012-04-05
CA2673370C (en) 2015-11-17
HRP20110464T1 (hr) 2011-07-31
US20120165539A1 (en) 2012-06-28
NO20092372L (no) 2009-07-14
CY1111596T1 (el) 2015-10-07
ATE503742T1 (de) 2011-04-15
KR101507717B1 (ko) 2015-04-08
US8497380B2 (en) 2013-07-30
DK2125736T3 (da) 2011-07-11
HK1135392A1 (en) 2010-06-04
JP2010513334A (ja) 2010-04-30
JP5342451B2 (ja) 2013-11-13
GT200900172A (es) 2011-10-05
CA2673370A1 (en) 2008-07-03
CR10877A (es) 2009-07-10
US20100035908A1 (en) 2010-02-11
BRPI0721113A2 (pt) 2014-10-07
EP2125736B1 (en) 2011-03-30

Similar Documents

Publication Publication Date Title
RU2493149C2 (ru) Замещенные метилфенилкетоны, пригодные для использования в качестве ингибиторов pde4
CN105683157B (zh) 用作钠通道调节剂的磺酰胺类
CA2683557C (en) Inhibitors of histone deacetylase
CN104968647B (zh) 作为钠通道调节剂的酰胺
JP5617919B2 (ja) テトラヒドロベンゾチオフェン化合物
TWI491595B (zh) 作為香草類化合物受體之配體之經取代苯基尿素及苯基醯胺
JP7170996B2 (ja) スルホンアミド誘導体またはその薬学的に許容される酸付加塩
US11851428B2 (en) Activator of TREK (TWIK RElated K+channels) channels
JP6505222B2 (ja) ヒストンリジン脱メチル化触媒活性を調節するための新規ピリドピリミジノン化合物
WO2005030734A1 (en) Diaminopyrimidine derivatives as selective growth hormone secrectgogue receptor (ghs-r) antagonists
JP2024527577A (ja) ３，４－メチレンジオキシメタンフェタミン及び関連する幻覚剤ならびにその使用
CN102304104A (zh) 一类trpv1拮抗剂、其制备方法及其医疗用途
CN107922391A (zh) 吡啶和嘧啶衍生物
JP2014518281A (ja) 電位依存性ナトリウムチャネル遮断薬
CN101611005B (zh) 用作pde4抑制剂的取代的苯乙酮类
AU2012203892A1 (en) Substituted acetophenones useful as PDE4 inhibitors
RS51736B (sr) Supstituisani acetofenoni korisni kao inhibitori pde4
CN120865048A (zh) Mas相关g蛋白受体x4调节剂及用途
HK1135392B (en) Substituted acetophenones useful as pde4 inhibitors
KR20040028769A (ko) 카텝신 억제제로서의 화합물 및 조성물
MXPA06012014A (en) Benzoxazocines and their therapeutic use as monoamine reuptake inhibitors

Legal Events

Date Code Title Description
MM4A The patent is invalid due to non-payment of fees

Effective date: 20191222